A Single-center, Open, Phase I Clinical Trial to Evaluate Safety of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months
Latest Information Update: 06 Sep 2021
At a glance
- Drugs Pneumococcal conjugate vaccine 15-valent-Beijing Zhifei Lvzhu Biopharmaceutical (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions
- Sponsors Beijing Zhifei Lvzhu Biopharmaceutical
- 09 Oct 2019 New trial record